What are you looking for today?

Amer, Ali A., Bingle, Lewis, Elkordy, Amal and Chaw, Cheng Shu (2025) Overcoming Oral Cavity Barriers for Peptide Delivery Using Advanced Pharmaceutical Techniques and Nano-Formulation Platforms. Biomedicines, 13 (11). p. 2735. ISSN 2227-9059

Document

Abstract

Abstract

Therapeutic peptides have gained significant attention due to their high specificity, potency, and safety profiles in treating various diseases. However, their clinical application via the oral route remains challenging. Peptides are inherently unstable in the gastrointestinal environment, where they are rapidly degraded by proteolytic enzymes and acidic pH, leading to poor bioavailability. Additionally, their large molecular size and hydrophilicity restrict passive diffusion across the epithelial barriers of the gastrointestinal tract. These limitations have traditionally necessitated parenteral administration, which reduces patient compliance and convenience. The oral cavity, comprising the buccal and sublingual mucosa, offers a promising alternative for peptide delivery. Its rich vascularization allows for rapid systemic absorption while bypassing hepatic first-pass metabolism. Furthermore, the mucosal surface provides a relatively permeable and accessible site for drug administration. However, the oral cavities also present significant barriers: the mucosal epithelium limits permeability, the presence of saliva causes rapid clearance, and enzymes in saliva contribute to peptide degradation. Therefore, innovative strategies are essential to enhance peptide stability, retention, and permeation in this environment. Nanoparticle-based delivery systems, including lipid-based carriers such as liposomes and niosomes, as well as polymeric nanoparticles like chitosan and PLGA, offer promising solutions. These nanocarriers protect peptides from enzymatic degradation, enhance mucoadhesion to prolong residence time, and facilitate controlled release. Their size and surface properties can be engineered to improve mucosal penetration, including through receptor-mediated endocytosis or by transiently opening tight junctions. Among these, niosomes have shown high encapsulation efficiency and sustained release potential, making them particularly suitable for oral peptide delivery. Despite advances, challenges remain in translating these technologies clinically, including ensuring biocompatibility, scalable manufacturing, and patient acceptance. Nevertheless, the oral cavity’s accessibility, combined with nanotechnological innovations, offers a compelling platform for personalized, non-invasive peptide therapies that could significantly improve treatment outcomes and patient quality of life.

Item Type: Article
Additional Information: ** Article version: VoR ** From Crossref journal articles via Jisc Publications Router ** History: epub 08-11-2025; issued 08-11-2025. ** Licence for VoR version of this article starting on 08-11-2025: https://creativecommons.org/licenses/by/4.0/
Related URLs:
SWORD Depositor: Publication Router
Depositing User: Amal Elkordy
URI: https://sure.sunderland.ac.uk/id/eprint/19666

Further Details

More Information

Additional Information
** Article version: VoR ** From Crossref journal articles via Jisc Publications Router ** History: epub 08-11-2025; issued 08-11-2025. ** Licence for VoR version of this article starting on 08-11-2025: https://creativecommons.org/licenses/by/4.0/
SWORD Depositor
Depositing User

Identifiers

Item ID
19666
Identification Number
ISSN
2227-9059

Users with ORCIDS

ORCID for Lewis Bingle
ORCID for Amal Elkordy
ORCID for Cheng Shu Chaw

Catalogue record

Date Deposited
02 Dec 2025 11:54
Last Modified
28 Jan 2026 12:38

Contributors

Author
Ali A. Amer

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year